Novel advances in cytochrome P450 research

Drug Discovery Today

Volumn 16, Issue 17-18, 2011, Pages 793-799

  Singh, Deepika ^a   Kashyap, Akriti ^a   Pandey, Ram Vinay ^b   Saini, Kulvinder Singh ^c  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b Institut fur Populationsgenetik   (Austria)

^c ETERNAL UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; MICRORNA; TAMOXIFEN; UNTRANSLATED RNA; XENOBIOTIC AGENT;

BREAST CANCER; CLINICAL RESEARCH; DRUG MECHANISM; DRUG RESPONSE; ENZYME POLYMORPHISM; ENZYME REGULATION; GENE EXPRESSION; GENOTYPE; HUMAN; LAB ON A CHIP; NANOCHIP; NONHUMAN; PSEUDOGENE; REVIEW; XENOBIOTIC METABOLISM;

ANIMALS; CYTOCHROME P-450 ENZYME SYSTEM; GENOTYPE; HALF-LIFE; HUMANS; METABOLIC DETOXICATION, DRUG; MICRORNAS; POLYMORPHISM, GENETIC; XENOBIOTICS;

EID: 80052847569     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2011.08.003     Document Type: Review

References (58)

1. M. Ingelman-Sundberg The human genome project and novel aspects of cytochrome P450 research Toxicol. Appl. Pharmacol. 207 2005 52 56
2. D.R. Nelson Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants Pharmacogenetics 14 2004 1 18 (Pubitemid 38183957)
3. N. Pinto, and M.E. Dolan Clinically relevant genetic variations in drug metabolizing enzymes Curr. Drug Metab. 12 2011 487 497
4. H. Veith Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries Nat. Biotechnol. 27 2009 1050 1055
5. G. Zlokarnik High throughput P450 inhibition screens in early drug discovery Drug Discov. Today 10 2005 1443 1450 (Pubitemid 41483873)
6. J.A. DiMasi The price of innovation: new estimates of drug development costs J. Health Econ. 22 2003 151 185
7. W. Zhang, and M.E. Dolan The emerging role of microRNAs in drug responses Curr. Opin. Mol. Ther. 12 2011 695 702
8. M. Pirmohamed, and B.K. Park Cytochrome P450 enzyme polymorphisms and adverse drug reactions Toxicology 192 2003 23 32 (Pubitemid 37153341)
9. K.A. Phillips Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review JAMA 286 2001 2270 2279 (Pubitemid 33063150)
10. N. Bushati, and S.M. Cohen microRNA functions Annu. Rev. Cell Dev. Biol. 23 2007 175 205
11. R.W. Carthew Gene regulation by microRNAs Curr. Opin. Genet. Dev. 16 2006 203 208 (Pubitemid 43376069)
12. Y. Lee MicroRNA genes are transcribed by RNA polymerase II EMBO J. 23 2004 4051 4060 (Pubitemid 39472426)
13. E.J. Devor Primate microRNAs miR-220 and miR-492 lie within processed pseudogenes J. Hered. 97 2006 186 190
14. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
15. E. Lund Nuclear export of microRNA precursors Science 303 2004 95 98 (Pubitemid 38055779)
16. J. Nagpal Targeting miRNAs for drug discovery: a new paradigm Curr. Mol. Med. 10 2010 503 510
17. A. Eulalio Getting to the root of miRNA-mediated gene silencing Cell 132 2008 9 14
18. M. Lagos-Quintana Identification of novel genes coding for small expressed RNAs Science 294 2001 853 858 (Pubitemid 33032103)
19. R.C. Lee, and V. Ambros An extensive class of small RNAs in Caenorhabditis elegans Science 294 2001 862 864 (Pubitemid 33032105)
20. N.R. Smalheiser EST analyses predict the existence of a population of chimeric microRNA precursor-mRNA transcripts expressed in normal human and mouse tissues Genome Biol. 4 2003 403
21. M.E. Peter Targeting of mRNAs by multiple miRNAs: the next step Oncogene 29 2010 2161 2164
22. B.P. Lewis Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell 120 2005 15 20 (Pubitemid 40094598)
23. E.S. Balakirev, and F.J. Ayala Molecular population genetics of the beta-esterase gene cluster of Drosophila melanogaster J. Genet. 82 2003 115 131 (Pubitemid 38650949)
24. A.J. Mighell Vertebrate pseudogenes FEBS Lett. 468 2000 109 114 (Pubitemid 30110777)
25. E.S. Balakirev, and F.J. Ayala Pseudogenes: are they "junk" or functional DNA? Annu. Rev. Genet. 37 2003 123 151 (Pubitemid 38041423)
26. A.N. Khachane, and P.M. Harrison Assessing the genomic evidence for conserved transcribed pseudogenes under selection BMC Genom. 10 2009 435
27. O.H. Tam Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes Nature 453 2008 534 538 (Pubitemid 351733314)
28. S. Hirotsune An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene Nature 423 2003 91 96 (Pubitemid 36569588)
29. J. Bristow Abundant adrenal-specific transcription of the human P450c21A "pseudogene" J. Biol. Chem. 268 1993 12919 12924 (Pubitemid 23182464)
30. A. Ramamoorthy, and T.C. Skaar In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes Drug Metab. Lett. 5 2011 126 131
31. V. Rusinov MicroInspector: a web tool for detection of miRNA binding sites in an RNA sequence Nucleic Acids Res. 33 2005 696 700
32. B. John Prediction of human microRNA targets Methods Mol. Biol. 342 2006 101 113
33. D.E. Kuhn Experimental validation of miRNA targets Methods 44 2008 47 54 (Pubitemid 350297983)
34. I.C. Henderson, and G.P. Canellos Cancer of the breast: the past decade (first of two parts) N. Engl. J. Med. 302 1980 17 30 (Pubitemid 10212232)
35. Y. Tsuchiya MicroRNA regulates the expression of human cytochrome P450 1B1 Cancer Res. 66 2006 9090 9098 (Pubitemid 44521128)
36. S. Griffiths-Jones The microRNA registry Nucleic Acids Res. 32 2004 109 111
37. M. Nakajima, and T. Yokoi MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors Pharmacol. Ther. 131 2011 330 337
38. T. Mohri Human CYP2E1 is regulated by miR-378 Biochem. Pharmacol. 79 2010 1045 1052
39. S. Kalscheuer Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone Carcinogenesis 29 2008 2394 2399
40. Y.Z. Pan MicroRNAs regulate CYP3A4 expression via direct and indirect targeting Drug Metab. Dispos. 37 2009 2112 2117
41. S. Takagi Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4 J. Biol. Chem. 283 2008 9674 9680
42. J. Ji Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation FEBS Lett. 583 2009 759 766
43. C.P. Granvil Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam Drug Metab. Dispos. 31 2003 548 558 (Pubitemid 36444163)
44. T. Mohri MicroRNA regulates human vitamin D receptor Int. J. Cancer 125 2009 1328 1333
45. S. Komagata Human CYP24 catalyzing the inactivation of calcitriol is post-transcriptionally regulated by miR-125b Mol. Pharmacol. 76 2009 702 709
46. S. Takagi MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle J. Biol. Chem. 285 2010 4415 4422
47. J. Krutzfeldt Silencing of microRNAs in vivo with 'antagomirs' Nature 438 2005 685 689
48. C. Esau miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting Cell Metab. 3 2006 87 98
49. I. Meijerman Pharmacogenetic screening of the gene deletion and duplications of CYP2D6 Drug Metab. Rev. 39 2007 45 60
50. M. Ingelman-Sundberg Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol. Ther. 116 2007 496 526 (Pubitemid 350116943)
51. M. Ingelman-Sundberg Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity Pharmacogenom. J. 5 2005 6 13 (Pubitemid 40220611)
52. V.O. Dezentje Clinical implications of CYP2D6 genotyping in tamoxifen treatment for breast cancer Clin. Cancer Res. 15 2009 15 21
53. J. de Leon Pharmacogenetic testing in psychiatry: a review of features and clinical realities Clin. Lab. Med. 28 2008 599 617
54. X. Li Clinical utility of microarrays: current status, existing challenges and future outlook Curr. Genom. 9 2008 466 474
55. M.W. Roederer Cytochrome P450 enzymes and genotype-guided drug therapy Curr. Opin. Mol. Ther. 11 2009 632 640
56. M.R. McClain A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding Genet. Med. 10 2008 89 98 (Pubitemid 351271719)
57. R.S. Epstein Warfarin genotyping reduces hospitalization rates results from the MM-WES (Medco-Mayo Warfarin Effectiveness study) J. Am. Coll. Cardiol. 55 2010 2804 2812
58. M.V. Holmes Fulfilling the promise of personalized medicine? Systematic review and field synopsis of pharmacogenetic studies PLoS One 4 2009 e7960